Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2020 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions.
Epigenomics. 2022 May;14(9):519-535. doi: 10.2217/epi-2022-0023. Epub 2022 Apr 6.
Epigenomics. 2022.
PMID: 35382559
Free PMC article.
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.
Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA.
Pattabiraman DR, et al.
Science. 2016 Mar 4;351(6277):aad3680. doi: 10.1126/science.aad3680.
Science. 2016.
PMID: 26941323
Free PMC article.
Item in Clipboard
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Brown MS, Abdollahi B, Wilkins OM, Lu H, Chakraborty P, Ognjenovic NB, Muller KE, Jolly MK, Christensen BC, Hassanpour S, Pattabiraman DR.
Brown MS, et al.
Sci Adv. 2022 Aug 5;8(31):eabj8002. doi: 10.1126/sciadv.abj8002. Epub 2022 Aug 3.
Sci Adv. 2022.
PMID: 35921406
Free PMC article.
Item in Clipboard
Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors.
Ognjenovic NB, Bagheri M, Mohamed GA, Xu K, Chen Y, Mohamed Saleem MA, Brown MS, Nagaraj SH, Muller KE, Gerber SA, Christensen BC, Pattabiraman DR.
Ognjenovic NB, et al.
Dev Cell. 2020 Dec 7;55(5):544-557.e6. doi: 10.1016/j.devcel.2020.10.004. Epub 2020 Oct 28.
Dev Cell. 2020.
PMID: 33120014
Free PMC article.
Item in Clipboard
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Bagheri M, Mohamed GA, Mohamed Saleem MA, Ognjenovic NB, Lu H, Kolling FW, Wilkins OM, Das S, LaCroix IS, Nagaraj SH, Muller KE, Gerber SA, Miller TW, Pattabiraman DR.
Bagheri M, et al.
Cell Rep Med. 2024 Apr 16;5(4):101504. doi: 10.1016/j.xcrm.2024.101504. Epub 2024 Apr 8.
Cell Rep Med. 2024.
PMID: 38593809
Free PMC article.
Item in Clipboard
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.
Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC.
Bagheri M, et al.
Epigenomics. 2024 Mar;16(5):293-308. doi: 10.2217/epi-2023-0339. Epub 2024 Feb 15.
Epigenomics. 2024.
PMID: 38356412
Item in Clipboard
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.
Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC.
Bagheri M, et al.
bioRxiv [Preprint]. 2023 Jun 10:2023.06.09.544426. doi: 10.1101/2023.06.09.544426.
bioRxiv. 2023.
PMID: 37333096
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite